Decipher by Veracyte

1.5K posts

Decipher by Veracyte banner
Decipher by Veracyte

Decipher by Veracyte

@Decipher_VCYT

Veracyte offers Decipher genomic tests for urologic cancers.

California Katılım Haziran 2011
564 Takip Edilen1.1K Takipçiler
Decipher by Veracyte
Decipher by Veracyte@Decipher_VCYT·
Join us March 12-14! The #DecipherProstate by Veracyte, Inc. team is at the Arkansas Urologic Society 2026 Annual Meeting in San Jonesboro, AR. Stop by to learn how we're helping transform #ProstateCancer care!
Decipher by Veracyte tweet media
English
0
0
0
62
Decipher by Veracyte
Decipher by Veracyte@Decipher_VCYT·
Happening Today! We’re excited to be attending the 2026 Emory Advances in Urology Course in Atlanta, GA, February 27! Stop by our booth to learn how #DecipherProstate by @Veracyte , Inc. delivers actionable insights that support informed decision-making in #ProstateCancer care.
Decipher by Veracyte tweet media
English
0
0
0
40
Decipher by Veracyte retweetledi
Julian Chavarriaga
Julian Chavarriaga@chavarriagaj·
#GU26 Dr Moningi examined Decipher in de novo mPCa: 🧬 Largest real-world linkage of transcriptomic + clinical data (n=135K) 🔎 509 de novo metastatic vs 10,689 matched localized 🔺 Higher Decipher scores (0.94 vs 0.75) 🔺 ↑ Luminal B (65%) & PTEN inactivity (25%) 🔺 More NCCN high/very high risk Biology matches the phenotype — genomically aggressive from the start. @ASCO @UroToday
Julian Chavarriaga tweet media
English
1
12
23
1.5K
Decipher by Veracyte retweetledi
European Urology Oncology
European Urology Oncology@EurUrolOncol·
This week's Editor's Choice! Prognostic Implications of Very High Decipher Scores in Prostate Cancer: Towards a Refined Genomic Risk Classification by Rohan Sharma et al Read the full article: buff.ly/pQTLspE Thank you to the authors for publishing in #euo @uroweb @mroupret @jteoh_hk @Ric_Campi @CaPsurvivorship @UroDocAsh @LauraMarandino @RenuEapen @Ecastromarcos @OncoAlert @Sciencedirect @rohanuro
English
0
2
7
1.1K
Decipher by Veracyte retweetledi
Adam B. Weiner, MD
Adam B. Weiner, MD@Adam_Weiner535·
🧬 Active surveillance (AS) ≠ one-size-fits-all for #ProstateCancer 🚨 New @EurUrolOncol data on Genomic Classifier (GC) in AS: 🔺High GC (≥0.6) → ↑ risk of major upgrading (GG≥3) 🔬↑ risk of unfavorable histology (IDC / cribriform) 🎯👀 Signals who may need closer surveillance, not overtreatment 🧠Risk-adapted AS matters 🔗shorturl.at/YHtQf @dr_coops @KShee11 @Decipher_VCYT @Davicioni @PCFnews @UrologyTimes @renalandurology @MRoupret
Adam B. Weiner, MD tweet mediaAdam B. Weiner, MD tweet mediaAdam B. Weiner, MD tweet media
English
1
25
74
6.7K